Home > Featured Products > Biotoxin Antibodies

Biotoxin Antibodies

Access biotoxin detection antibodies for mycotoxins (aflatoxin, ochratoxin, DON), bacterial toxins, and marine biotoxins. Validated for ELISA, lateral flow, and immunoassay. RUO

Why Researchers Choose abinScience

Highly Specialized Reagents Purpose-built antibodies for niche research applications with validated performance data on every datasheet.

Rigorous Application Validation Each antibody tested in relevant applications with supporting images and quantitative data.

Original Manufacturer Developed and produced in-house — full traceability, batch consistency, and competitive pricing.

Technical Expert Support Application scientists available for reagent selection, protocol optimization, and troubleshooting.

Flexible Options Unconjugated and conjugated formats; bulk quantities and custom conjugation available on request.

Documents & QC Data

Download product datasheets, validation images (WB/IHC/IF/FC), CoA, and application protocols on each product page. All data is lot-specific.

FAQs

How are your antibodies validated?

Every antibody is validated in its listed applications (WB, IHC, IF, ELISA, FC) with supporting images and data on the product page. We use positive and negative controls plus knockout/knockdown verification where available.

Do you offer conjugated antibodies?

Yes — HRP, AP, biotin, FITC, PE, APC, Alexa Fluor, and other fluorochrome conjugates are available. Custom conjugation services are also offered for bulk orders.

What species do your antibodies react with?

Most antibodies target human, mouse, and rat. Many show validated cross-reactivity with additional species. Check the product datasheet for confirmed reactivity data.

What is your replacement policy?

If a product does not perform as described under recommended conditions, contact us within 30 days for replacement or credit. Our technical team will help troubleshoot first.

Can I get custom antibodies?

Yes — our parent company AtaGenix offers full custom antibody development from immunogen design through hybridoma screening and scale-up production.